Up-regulation of fatty acid synthase induced by EGFR/ERK activation promotes tumor growth in pancreatic cancer

Biochemical and Biophysical Research Communications

Volumn 463, Issue 4, 2015, Pages 612-617

  Bian, Yong ^a   Yu, Yun ^a   Wang, Shanshan ^a   Li, Lin ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

EGFR; FASN; Growth; Pancreatic cancer

Indexed keywords

FATTY ACID SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; RNA; SMALL INTERFERING RNA; VASCULOTROPIN RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PRIMER DNA;

ADULT; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL; TISSUE MICROARRAY; UPREGULATION; CELL DIVISION; ENZYMOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

BASE SEQUENCE; CARCINOMA, PANCREATIC DUCTAL; CELL DIVISION; CELL LINE, TUMOR; DNA PRIMERS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FATTY ACID SYNTHASES; HUMANS; PANCREATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84936890771     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.05.108     Document Type: Article

References (39)

1. O. The Lancet Pancreatic cancer in the spotlight Lancet Oncol. 15 2014 241
2. R.L. Siegel, K.D. Miller, and A. Jemal Cancer statistics, 2015 CA. Cancer J. Clin. 65 2015 5 29
3. S.J. Wakil, and L.A. Abu-Elheiga Fatty acid metabolism: target for metabolic syndrome J. Lipid Res. 50 Suppl 2009 S138 S143
4. F.P. Kuhajda Fatty acid synthase and cancer: new application of an old pathway Cancer Res. 66 2006 5977 5980
5. F.P. Kuhajda Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology Nutrition 16 2000 202 208
6. S.M. Cabarcas, E.M. Hurt, and W.L. Farrar Defining the molecular nexus of cancer, type 2 diabetes and cardiovascular disease Curr. Mol. Med. 10 2010 744 755
7. J.L. Little, and S.J. Kridel Fatty acid synthase activity in tumor cells Subcell. Biochem. 49 2008 169 194
8. J.A. Menendez, A. Vazquez-Martin, F.J. Ortega, and J.M. Fernandez-Real Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer Clin. Chem. 55 2009 425 438
9. M. Lopez, C.J. Lelliott, and A. Vidal-Puig Hypothalamic fatty acid metabolism: a housekeeping pathway that regulates food intake Bioessays 29 2007 248 261
10. J.K. Suagee, B.A. Corl, M.V. Crisman, J.G. Wearn, L.J. McCutcheon, and R.J. Geor De novo fatty acid synthesis and NADPH generation in equine adipose and liver tissue Comp. Biochem. Physiol. B Biochem. Mol. Biol. 155 2010 322 326
11. A.S. Tarun, A.M. Vaughan, and S.H. Kappe Redefining the role of de novo fatty acid synthesis in Plasmodium parasites Trends Parasitol. 25 2009 545 550
12. S.Y. Bu, M.T. Mashek, and D.G. Mashek Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity J. Biol. Chem. 284 2009 30474 30483
13. T. Mashima, H. Seimiya, and T. Tsuruo De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy Br. J. Cancer 100 2009 1369 1372
14. S. Baud, and L. Lepiniec Regulation of de novo fatty acid synthesis in maturing oilseeds of Arabidopsis Plant Physiol. Biochem. 47 2009 448 455
15. S. Uddin, A.R. Hussain, M. Ahmed, J. Abubaker, N. Al-Sanea, A. Abduljabbar, L.H. Ashari, S. Alhomoud, F. Al-Dayel, P. Bavi, and K.S. Al-Kuraya High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target Am. J. Gastroenterol. 104 2009 1790 1801
16. T. Sugino, K. Baba, N. Hoshi, K. Aikawa, O. Yamaguchi, and T. Suzuki Overexpression of fatty acid synthase in human urinary bladder cancer and combined expression of the synthase and Ki-67 as a predictor of prognosis of cancer patients Med. Mol. Morphol. 44 2011 146 150
17. M.S. Shurbaji, J.H. Kalbfleisch, and T.S. Thurmond Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer Hum. Pathol. 27 1996 917 921
18. T.S. Gansler, W. Hardman 3rd, D.A. Hunt, S. Schaffel, and R.A. Hennigar Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival Hum. Pathol. 28 1997 686 692
19. C.J. Piyathilake, A.R. Frost, U. Manne, W.C. Bell, H. Weiss, D.C. Heimburger, and W.E. Grizzle The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung Hum. Pathol. 31 2000 1068 1073
20. T. Takahiro, K. Shinichi, and S. Toshimitsu Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas Clin. Cancer Res. 9 2003 2204 2212
21. D. Innocenzi, P.L. Alo, A. Balzani, V. Sebastiani, V. Silipo, G. La Torre, G. Ricciardi, C. Bosman, and S. Calvieri Fatty acid synthase expression in melanoma J. Cutan. Pathol. 30 2003 23 28
22. E.S. Pizer, F.J. Chrest, J.A. DiGiuseppe, and W.F. Han Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines Cancer Res. 58 1998 4611 4615
23. E.S. Pizer, C. Jackisch, F.D. Wood, G.R. Pasternack, N.E. Davidson, and F.P. Kuhajda Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells Cancer Res. 56 1996 2745 2747
24. P.L. Alo, M. Amini, F. Piro, L. Pizzuti, V. Sebastiani, C. Botti, R. Murari, G. Zotti, and U. Di Tondo Immunohistochemical expression and prognostic significance of fatty acid synthase in pancreatic carcinoma Anticancer Res. 27 2007 2523 2527
25. A.K. Witkiewicz, K.H. Nguyen, A. Dasgupta, E.P. Kennedy, C.J. Yeo, M.P. Lisanti, and J.R. Brody Co-expression of fatty acid synthase and caveolin-1 in pancreatic ductal adenocarcinoma: implications for tumor progression and clinical outcome Cell. Cycle 7 2008 3021 3025
26. M.F. Santolla, R. Lappano, P. De Marco, M. Pupo, A. Vivacqua, D. Sisci, S. Abonante, D. Iacopetta, A.R. Cappello, V. Dolce, and M. Maggiolini G protein-coupled estrogen receptor mediates the up-regulation of fatty acid synthase induced by 17beta-estradiol in cancer cells and cancer-associated fibroblasts J. Biol. Chem. 287 2012 43234 43245
27. C. Navas, I. Hernandez-Porras, A.J. Schuhmacher, M. Sibilia, C. Guerra, and M. Barbacid EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma Cancer Cell. 22 2012 318 330
28. C.M. Ardito, B.M. Gruner, K.K. Takeuchi, C. Lubeseder-Martellato, N. Teichmann, P.K. Mazur, K.E. Delgiorno, E.S. Carpenter, C.J. Halbrook, J.C. Hall, D. Pal, T. Briel, A. Herner, M. Trajkovic-Arsic, B. Sipos, G.Y. Liou, P. Storz, N.R. Murray, D.W. Threadgill, M. Sibilia, M.K. Washington, C.L. Wilson, R.M. Schmid, E.W. Raines, H.C. Crawford, and J.T. Siveke EGF receptor is required for KRAS-induced pancreatic tumorigenesis Cancer Cell. 22 2012 304 317
29. A. Legaspi, M. Jeevanandam, H.F. Starnes Jr., and M.F. Brennan Whole body lipid and energy metabolism in the cancer patient Metabolism 36 1987 958 963
30. A. Hyltander, C. Drott, U. Korner, R. Sandstrom, and K. Lundholm Elevated energy expenditure in cancer patients with solid tumours Eur. J. Cancer 27 1991 9 15
31. Y.Y. Zaytseva, V.A. Elliott, P. Rychahou, W.C. Mustain, J.T. Kim, J. Valentino, T. Gao, K.L. O'Connor, J.M. Neltner, E.Y. Lee, H.L. Weiss, and B.M. Evers Cancer cell-associated fatty acid synthase activates endothelial cells and promotes angiogenesis in colorectal cancer Carcinogenesis 35 2014 1341 1351
32. N. Li, X. Bu, X. Tian, P. Wu, L. Yang, and P. Huang Fatty acid synthase regulates proliferation and migration of colorectal cancer cells via HER2-PI3K/Akt signaling pathway Nutr. Cancer 64 2012 864 870
33. Y.Y. Zaytseva, P.G. Rychahou, P. Gulhati, V.A. Elliott, W.C. Mustain, K. O'Connor, A.J. Morris, M. Sunkara, H.L. Weiss, E.Y. Lee, and B.M. Evers Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer Cancer Res. 72 2012 1504 1517
34. A. Horiguchi, T. Asano, T. Asano, K. Ito, M. Sumitomo, and M. Hayakawa Pharmacological inhibitor of fatty acid synthase suppresses growth and invasiveness of renal cancer cells J. Urol. 180 2008 729 736
35. V. Sebastiani, P. Visca, C. Botti, G. Santeusanio, G.M. Galati, V. Piccini, B. Capezzone de Joannon, U. Di Tondo, and P.L. Alo Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma Gynecol. Oncol. 92 2004 101 105
36. S. Ogino, K. Nosho, J.A. Meyerhardt, G.J. Kirkner, A.T. Chan, T. Kawasaki, E.L. Giovannucci, M. Loda, and C.S. Fuchs Cohort study of fatty acid synthase expression and patient survival in colon cancer J. Clin. Oncol. 26 2008 5713 5720
37. T. Van de Sande, E. De Schrijver, W. Heyns, G. Verhoeven, and J.V. Swinnen Role of the phosphatidylinositol 3′-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells Cancer Res. 62 2002 642 646
38. E. Rysman, K. Brusselmans, K. Scheys, L. Timmermans, R. Derua, S. Munck, P.P. Van Veldhoven, D. Waltregny, V.W. Daniels, J. Machiels, F. Vanderhoydonc, K. Smans, E. Waelkens, G. Verhoeven, and J.V. Swinnen De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation Cancer Res. 70 2010 8117 8126
39. E.S. Pizer, S.F. Lax, F.P. Kuhajda, G.R. Pasternack, and R.J. Kurman Fatty acid synthase expression in endometrial carcinoma: correlation with cell proliferation and hormone receptors Cancer 83 1998 528 537